ArticleAmerican journal of ophthalmology2026
Artificial Intelligence-Guided Endpoint Selection for Neuroprotection Trials in Glaucoma.
Douglas R da Costa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it